Status:
RECRUITING
Covid-19 in Hematological Malignancies
Lead Sponsor:
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
Collaborating Sponsors:
European Hematology Association
Conditions:
COVID-19 Infection in Hematological Malignancies Patients
Eligibility:
All Genders
18-99 years
Brief Summary
The overall purpose of this project is to better understand the epidemiology of COVID-19 in patients with hematological malignancies (including hematopoietic stem cell transplant recipients) in the di...
Detailed Description
At the moment, few data on the epidemiology of SARS-CoV-2 infection in patients suffering from hematological malignancies are available. However, the COVID-19 pandemic presents unique challenges and o...
Eligibility Criteria
Inclusion
- Age equal to or greater than 18 years of age.
- History of hematological malignancies (acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas, myeloma, chronic myeloprolipherative disorders) at any stage/status.
- Active hematological malignancies at any stage/status.
- Diagnosis of hematological malignancy (acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas, myeloma, chronic myeloprolipherative disorders) at any stage/status.
- SARS-CoV-2 positive test (nasopharyngeal, BAL, fecal), documented by Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panels.
Exclusion
- Hematological diseases, other than hematological malignancies.
- Not tested positive for SARS-CoV-2
- Patients "off therapy" for more than 5 years
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04733729
Start Date
March 1 2020
End Date
December 31 2025
Last Update
May 29 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST-Spedali Civili
Brescia, Italy
2
AOU Policlinico Federico II
Napoli, Italy
3
Fondazione Policlinico A. Gemelli IRCCS
Rome, Italy
4
Istituto Nazionale Tumori Regina Elena IFO
Rome, Italy